LEXINGTON, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the ...

LEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the ...

LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...

LEXINGTON, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the ...

A Billerica landlord is suing T2 Biosystems for damages resulting from the biotech company abandoning its lease. Farley White sent a notice Jan. 17 that it was terminating the tenant's 70K SF lease at ...

T2 Biosystems, Inc. (NASDAQ:TTOO) shares are trading higher Tuesday, though the stock remains down by more than 75% over the last month. On Monday, T2 Biosystems announced the successful amendment and ...

Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test. In a statement Tuesday, T2 Biosystems TTOO ...

LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced ...

T2 Biosystems has raised $23 million through series D venture capital financing. The investment round was led by new investor Aisling Capital, while existing investors, including Flagship Ventures, ...

T2 Biosystems, Inc. (NASDAQ:TTOO) shares are trading higher on Tuesday. Despite the gains, the stock is down nearly 100% year-to-date. What To Know: Shares of T2 Biosystems took a nosedive in ...